Hyperglycemia-dependent DRP1 activation increases reticulum-mitochondria calcium exchange and heart vulnerability to ischemia-reperfusion, which is reduced by DRP1 inhibition with Mdivi-1.
Does DRP1 inhibition reduce heart sensitivity to ischemia-reperfusion injury in hyperglycemic conditions?
Hyperglycemia-dependent DRP1 activation increases reticulum-mitochondria calcium exchange, contributing to higher heart vulnerability to ischemia-reperfusion injury, which can be mitigated by DRP1 inhibition.
Hyperglycemia increases the heart sensitivity to ischemia-reperfusion (IR), but the underlying cellular mechanisms remain unclear. Mitochondrial dynamics (the processes that govern mitochondrial morphology and their interactions with other organelles, such as the reticulum), has emerged as a key factor in the heart vulnerability to IR. However, it is unknown whether mitochondrial dynamics contributes to hyperglycemia deleterious effect during IR. We hypothesized that (i) the higher heart vulnerability to IR in hyperglycemic conditions could be explained by hyperglycemia effect on the complex interplay between mitochondrial dynamics, Ca2+ homeostasis, and reactive oxygen species (ROS) production; and (ii) the activation of DRP1, a key regulator of mitochondrial dynamics, could play a central role. Using transmission electron microscopy and proteomic analysis, we showed that the interactions between sarcoplasmic reticulum and mitochondria and mitochondrial fission were increased during IR in isolated rat hearts perfused with a hyperglycemic buffer compared with hearts perfused with a normoglycemic buffer. In isolated mitochondria and cardiomyocytes, hyperglycemia increased mitochondrial ROS production and Ca2+ uptake. This was associated with higher RyR2 instability. These results could contribute to explain the early mPTP activation in mitochondria from isolated hearts perfused with a hyperglycemic buffer and in hearts from streptozotocin-treated rats (to increase the blood glucose). DRP1 inhibition by Mdivi-1 during the hyperglycemic phase and before IR induction, normalized Ca2+ homeostasis, ROS production, mPTP activation, and reduced the heart sensitivity to IR in streptozotocin-treated rats. In conclusion, hyperglycemia-dependent DRP1 activation results in higher reticulum-mitochondria calcium exchange that contribute to the higher heart vulnerability to IR.
Dubois et al. (Fri,) conducted a other in Ischemia-reperfusion injury. Hyperglycemia and DRP1 inhibition (Mdivi-1) vs. Normoglycemia was evaluated on Heart sensitivity to ischemia-reperfusion, mitochondrial ROS production, and Ca2+ uptake. Hyperglycemia-dependent DRP1 activation increases reticulum-mitochondria calcium exchange and heart vulnerability to ischemia-reperfusion, which is reduced by DRP1 inhibition with Mdivi-1.